Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dermal inflammation and hyaluronan in psoriatic arthritis treated with adalimumab
2012-004940-31Phase 4Active
- Sponsor
- Department of Medical Sciences
- Start
- Apr 2013
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 4, open-label trial of adalimumab in psoriatic arthritis (PsA) (2 arms), sponsored by Department of Medical Sciences. Started Apr 2013; status: active.
02
Drugs
03
Conditions
psoriatic arthritis (PsA)
Beyond the preview
Go deeper on 2012-004940-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-004940-31.